Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 2.14B | $ 2.95B | $ 2.06B | $ 2.53B | $ 1.81B |
Total Assets | $ 238.69B | $ 225.72B | $ 217.90B | $ 209.88B | $ 203.19B |
Total Debt | $ 54.07B | $ 55.48B | $ ― | $ ― | $ ― |
Net Debt | $ 51.93B | $ 52.53B | $ ― | $ ― | $ ― |
Total Liabilities | $ 67.83B | $ 62.73B | $ 54.83B | $ 51.19B | $ 49.16B |
Stockholders Equity | $ 170.57B | $ 162.69B | $ 163.04B | $ 158.72B | $ 153.85B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |